Hand Function pp 245-250 | Cite as

Hand Function in Cancer

  • Feray Soyupek


With improvement in cancer and increase in survival time, the accompanying problems are increasing. Chemotherapy, radiation therapy, surgery, lymphedema, and direct effects of cancer can cause problems in upper extremities and also in hands. It is important to identify cancer-related hand problems and to focus on these problems in cancer rehabilitation. In this chapter, upper extremity and hand involvements in cancers were mentioned.


Cancer Hand function Upper extremities 


  1. 1.
    World Cancer Research Fund International.
  2. 2.
    Shabbir MH, Breunis H, Timilshina N, Naglie G, Tannock I, Krahn M, Warde P, Fleshner NE, Canning SD, Tomlinson G. Long term effect of androgen deprivation therapy on physical function and quality of life. Cancer. 2015;121(14):2350–7.CrossRefGoogle Scholar
  3. 3.
    Somanchi BV, Stanton A, Webb M, Loncaster J, Allan E, Muir LT. Hand function after high dose rate brachytherapy for squamous cell carcinoma of the skin of the hand. Clin Oncol (R Coll Radiol). 2008;20(9):691–7.CrossRefGoogle Scholar
  4. 4.
    Recchia TL, Prim AC, Luz CM. Upper limb functionality and quality of life in women with five-year survival after breast cancer surgery. Rev Bras Ginecol Obstet. 2017;39(3):115–22.PubMedCrossRefGoogle Scholar
  5. 5.
    Ibrahim M, Muanza T, Smirnow N, Sateren W, Fournier B, Kavan P, Palumbo M, Dalfen R, Dalzell MA. Time course of upper limb function and return-to-work post-radiotherapy in young adults with breast cancer: a pilot randomized control trial on effects of targeted exercise program. J Cancer Surviv. 2017;11(6):791–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Karadibak D, Yavuzsen T. Evaluation of kinesthetic sense and hand function in women with breast cancer-related lymphedema. J Phys Ther Sci. 2015;27(6):1671–5.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Hayes S, Battistutta D, Newman B. Objective and subjective upper body function six months following diagnosis of breast cancer. Breast Cancer Res Treat. 2005;94(1):1–10.PubMedCrossRefGoogle Scholar
  8. 8.
    Gane EM, O’Leary SP, Hatton AL, Panizza BJ, McPhail SM. Neck and upper limb dysfunction in patients following neck dissection: looking beyond the shoulder. Otolaryngol Head Neck Surg. 2017;157(4):631–40.PubMedCrossRefGoogle Scholar
  9. 9.
    Soyupek F, Soyupek S, Perk H, Ozorak A. Androgen deprivation therapy for prostate cancer: effects on hand function. Urol Oncol. 2008;26(2):141–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Pinto M, Gimigliano F, Tatangelo F, Megna M, Izzo F, Gimigliano R, Iolascon G. Upper limb function and quality of life in breast cancer related lymphedema: a cross-sectional study. Eur J Phys Rehabil Med. 2013;49(5):665–73.PubMedGoogle Scholar
  11. 11.
    Grisold W, Cavaletti G, Windebank AJ. Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro-Oncology. 2012;14(Suppl 4):iv45–54.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    de Jong N, Candel MJ, Schouten HC, Abu-Saad HH, Courtens AM. Prevalence and course of fatigue in breast cancer patients receiving adjuvant chemotherapy. Ann Oncol. 2004;15(6):896–905.PubMedCrossRefGoogle Scholar
  13. 13.
    Jansen CE, Miaskowski C, Dodd M, Dowling G, Kramer J. A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer. 2005;104(10):2222–33.PubMedCrossRefGoogle Scholar
  14. 14.
    Yang EJ, Park WB, Seo KS, Kim SW, Heo CY, Lim JY. Longitudinal change of treatment-related upper limb dysfunction and its impact on late dysfunction in breast cancer survivors: a prospective cohort study. J Surg Oncol. 2010;101(1):84–91.PubMedCrossRefGoogle Scholar
  15. 15.
    Fink JA, Akelman E. Nonmelanotic malignant skin tumors of the hand. Hand Clin. 1995;11(2):255–64.PubMedGoogle Scholar
  16. 16.
    TerKonda SP, Perdikis G. Non-melanotic skin tumors of the upper extremity. Hand Clin. 2004;20(3):293–301.PubMedCrossRefGoogle Scholar
  17. 17.
    Haws MJ, Neumeister MW, Kenneaster DG, Russell RC. Management of nonmelanoma skin tumors of the hand. Clin Plast Surg. 1997;24(4):779–95.PubMedGoogle Scholar
  18. 18.
    Forsythe RL, Bajaj P, Engeron O, Shadid EA. The treatment of squamous cell carcinoma of the hand. Hand. 1978;10(1):104–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Kumar PP. Metastases to the bones of the hand. J Natl Med Assoc. 1975l;67(4):275–6.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Carvalho Hde A, Tsai PW, Takagaki TY. Thumb metastasis from small cell lung cancer treated with radiation. Rev Hosp Clin Fac Med Sao Paulo. 2002;57(6):283–6.CrossRefGoogle Scholar
  21. 21.
    Christensen JF, Jones LW, Andersen JL, Daugaard G, Rorth M, Hojman P. Muscle dysfunction in cancer patients. Ann Oncol. 2014;25(5):947–58.PubMedCrossRefGoogle Scholar
  22. 22.
    Burden ST, Hill J, Shaffer JL, Todd C. Nutritional status of preoperative colorectal cancer patients. J Hum Nutr Diet. 2010;23(4):402–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Alibhai SM, Breunis H, Timilshina N, Johnston C, Tomlinson G, Tannock I, Krahn M, Fleshner NE, Warde P, Canning SD, Klotz L, Naglie G. Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer. J Clin Oncol. 2011;28(34):5038–45.CrossRefGoogle Scholar
  24. 24.
    De Groef A, Meeus M, De Vrieze T, Vos L, Van Kampen M, Christiaens MR, Neven P, Geraerts I, Devoogdt N. Pain characteristics as important contributing factors to upper limb dysfunctions in breast cancer survivors at long term. Musculoskelet Sci Pract. 2017;29:52–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Rietman JS, Geertzen JH, Hoekstra HJ, Baas P, Dolsma WV, de Vries J, Groothoff JW, Eisma WH, Dijkstra PU. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol. 2006;32(2):148–52.PubMedCrossRefGoogle Scholar
  26. 26.
    Hidding JT, Beurskens CH, van der Wees PJ, van Laarhoven HW, Nijhuis-van der Sanden MW. Treatment related impairments in arm and shoulder in patients with breast cancer: a systematic review. PLoS One. 2014;9(5):e96748.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Hayes SC, Johansson K, Stout NL, Prosnitz R, Armer JM, Gabram S, Schmitz KH. Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care. Cancer. 2012;118(8 Suppl):2237–49.PubMedCrossRefGoogle Scholar
  28. 28.
    Levangie PK, Drouin J. Magnitude of late effects of breast cancer treatments on shoulder function: a systematic review. Breast Cancer Res Treat. 2009;116(1):1–15.PubMedCrossRefGoogle Scholar
  29. 29.
    Kootstra JJ, Dijkstra PU, Rietman H, de Vries J, Baas P, Geertzen JH, Hoekstra HJ, Hoekstra-Weebers JE. A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection. Breast Cancer Res Treat. 2013;139(1):125–34.PubMedCrossRefGoogle Scholar
  30. 30.
    De Groef A, Van Kampen M, Tieto E, Schönweger P, Christiaens MR, Neven P, Geraerts I, Gebruers N, Devoogdt N. Arm lymphoedema and upper limb impairments in sentinel node-negative breast cancer patients: a one year follow-up study. Breast. 2016;29:102–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Harrington S, Padua D, Battaglini C, Michener LA. Upper extremity strength and range of motion and their relationship to function in breast cancer survivors. Physiother Theory Pract. 2013;29(7):513–20.PubMedCrossRefGoogle Scholar
  32. 32.
    DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500–15.PubMedCrossRefGoogle Scholar
  33. 33.
    Sherman KA, Miller SM, Roussi P, Taylor A. Factors predicting adherence to risk management behaviors of women at increased risk for developing lymphedema. Support Care Cancer. 2015;23(1):61–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Caffo O, Amichetti M, Ferro A, Lucenti A, Valduga F, Galligioni E. Pain and quality of life after surgery for breast cancer. Breast Cancer Res Treat. 2003;80(1):39–48.PubMedCrossRefGoogle Scholar
  35. 35.
    Voogd AC, Ververs JM, Vingerhoets AJ, Roumen RM, Coebergh JW, Crommelin MA. Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer. Br J Surg. 2003;90(1):76–81.PubMedCrossRefGoogle Scholar
  36. 36.
    Borthwick Y, Paul L, Sneddon M, McAlpine L, Miller C. Reliability and validity of the figure-of-eight method of measuring hand size in patients with breast cancer-related lymphoedema. Eur J Cancer Care (Engl). 2013;22(2):196–201.CrossRefGoogle Scholar
  37. 37.
    Hwang R, Kentish M, Burns Y. Hand positioning sense in children with spina bifida myelomeningocele. Aust J Physiother. 2002;48(1):17–22.PubMedCrossRefGoogle Scholar
  38. 38.
    Kara B, Yildirim Y, Karadıbak D, Acar U. Evaluation of the kinesthetic sense and function of the hand in early period in operated cervical disc hernia. Eur Spine J. 2006;15(6):992–7.PubMedCrossRefGoogle Scholar
  39. 39.
    Harrington S, Michener LA, Kendig T, Miale S, George SZ. Patient-reported upper extremity outcome measures used in breast cancer survivors: a systematic review. Arch Phys Med Rehabil. 2014;95(1):153–62.PubMedCrossRefGoogle Scholar
  40. 40.
    Smoot B, Wong J, Cooper B, Wanek L, Topp K, Byl N, Dodd M. Upper extremity impairments in women with or without lymphedema following breast cancer treatment. J Cancer Surviv. 2010;4(2):167–78.PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Velloso FS, Barra AA, Dias RC. Functional performance of upper limb and quality of life after sentinel lymph node biopsy of breast cancer. Rev Bras Fisioter. 2011;15(2):146–53.PubMedCrossRefGoogle Scholar
  42. 42.
    Levy EW, Pfalzer LA, Danoff J, Springer BA, McGarvey C, Shieh CY, Morehead-Gee A, Gerber LH, Stout NL. Predictors of functional shoulder recovery at 1 and 12 months after breast cancer surgery. Breast Cancer Res Treat. 2012;134(1):315–24.PubMedCrossRefGoogle Scholar
  43. 43.
    Wampler MA, Miaskowsky C, Hamel K, Byl N, Rugo H, Topp KS. The modified total neuropathy score: a clinically feasible and valid measure of taxane induced peripheral neuropathy in women with breast cancer. J Support Oncol. 2006;4:9–16.Google Scholar
  44. 44.
    Dawes DJ, Meterissian S, Goldberg M, Mayo NE. Impact of lymphoedema on arm function and health-related quality of life in women following breast cancer surgery. J Rehabil Med. 2008;40(8):651–8.PubMedCrossRefGoogle Scholar
  45. 45.
    Lee D, Hwang JH, Chu I, Chang HJ, Shim YH, Kim JH. Analysis of factors related to arm weakness in patients with breast cancer-related lymphedema. Support Care Cancer. 2015;23(8):2297–304.PubMedCrossRefGoogle Scholar
  46. 46.
    Sagen A, Kaaresen R, Sandvik L, Thune I, Risberg MA. Upper limb physical function and adverse effects after breast cancer surgery: a prospective 2.5-year follow-up study and preoperative measures. Arch Phys Med Rehabil. 2014;95(5):875–81.PubMedCrossRefGoogle Scholar
  47. 47.
    American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2008;31(Suppl 1):12–54.CrossRefGoogle Scholar
  48. 48.
    Dutch Association of Neurology (NVN), Dutch Association of Clinical Neurophysiology (NVKNF). Guideline Polyneuropathy of the Dutch Institute for Healthcare Improvement (CBO). Alphen aan den Rijn: van Zuiden; 2005.Google Scholar
  49. 49.
    Carr SD, Bowyer D, Cox G. Upper limb dysfunction following selective neck dissection: a retrospective questionnaire study. Head Neck. 2009;31(6):789–92.PubMedCrossRefGoogle Scholar
  50. 50.
    Chan JY, Wong ST, Chan RC, Wei WI. Shoulder dysfunction after selective neck dissection in recurrent nasopharyngeal carcinoma. Otolaryngol Head Neck Surg. 2015;153(3):379–84.PubMedCrossRefGoogle Scholar
  51. 51.
    Katz D, Koppie TM, Wu D, Meng MV, Grossfeld GD, Sadesky N, Lubeck DP, Carroll PR. Sociodemographic characteristics and health related quality of life in men attending prostate cancer support groups. J Urol. 2002;168(5):2092–6.PubMedCrossRefGoogle Scholar
  52. 52.
    Meng MV, Grossfeld GD, Sadetsky N, Mehta SS, Lubeck DP, Carroll PR. Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer. Urology. 2002;60(3 Suppl 1):7–11.PubMedCrossRefGoogle Scholar
  53. 53.
    Ling CH, Taekema D, de Craen AJ, Gussekloo J, Westendorp RG, Maier AB. Handgrip strength and mortality in the oldest old population: the Leiden 85-plus study. CMAJ. 2010;182(5):429–35.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Feray Soyupek
    • 1
  1. 1.Department of Physical Medicine and RehabilitationSüleyman Demirel University HospitalIspartaTurkey

Personalised recommendations